1,2-benzisothiazoline-3-one has been researched along with 2-phenyl-1,2-benzisothiazol-3-(2h)-one in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Baggaley, KH; English, PD; Jennings, LJ; Morgan, B; Nunn, B; Tyrrell, AW | 1 |
Liu, D; Liu, W; Ma, Y; Tian, Z; Wang, Q; Wu, L; Yan, Z; Yang, C; Zhou, H | 1 |
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
Cao, H; Chen, H; Han, X; Huang, Y; Liu, J; Peng, C; Rao, L; Ren, Y; Sheng, C; Su, C; Tu, J; Wan, C; Wan, J; Wen, W | 1 |
4 other study(ies) available for 1,2-benzisothiazoline-3-one and 2-phenyl-1,2-benzisothiazol-3-(2h)-one
Article | Year |
---|---|
Inhibitors of blood platelet aggregation. Effects of some 1,2-benzisothiazol-3-ones on platelet responsiveness to adenosine diphosphate and collagen.
Topics: Adenosine Diphosphate; Animals; Chemical Phenomena; Chemistry; Collagen; Guinea Pigs; Humans; Male; Platelet Aggregation; Rats; Structure-Activity Relationship; Thiazoles | 1985 |
Design, synthesis and evaluation of 1,2-benzisothiazol-3-one derivatives as potent caspase-3 inhibitors.
Topics: Caspase 3; Caspase Inhibitors; Drug Design; Enzyme Assays; High-Throughput Screening Assays; Humans; Molecular Docking Simulation; Recombinant Proteins; Structure-Activity Relationship; Thiazoles | 2013 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
Structure-Guided Discovery of the Novel Covalent Allosteric Site and Covalent Inhibitors of Fructose-1,6-Bisphosphate Aldolase to Overcome the Azole Resistance of
Topics: Allosteric Site; Antifungal Agents; Azoles; Biofilms; Candida albicans; Candida parapsilosis; Drug Resistance, Fungal; Enzyme Inhibitors; Fructose-Bisphosphate Aldolase; Fungal Proteins; Microbial Sensitivity Tests; Molecular Structure; Protein Binding; Structure-Activity Relationship | 2022 |